Pinnacle Bancorp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pinnacle Bancorp’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19	Closed	-$3.59K	–	929
2026 Q1	$3.59K	Sell	19 -7	-27%	-$1.22K	﹤0.01%	833
2025 Q4	$4.42K	Hold	26	–	–	﹤0.01%	798
2025 Q3	$3.43K	Sell	26 -21	-45%	-$2.52K	﹤0.01%	838
2025 Q2	$4.99K	Hold	47	–	–	﹤0.01%	798
2025 Q1	$5.83K	Hold	47	–	–	﹤0.01%	758
2024 Q4	$5.79K	Hold	47	–	–	﹤0.01%	771
2024 Q3	$5.24K	Hold	47	–	–	﹤0.01%	775
2024 Q2	$5.02K	Buy	47 +11	+31%	+$1.21K	﹤0.01%	755
2024 Q1	$4.33K	Buy	36 +19	+112%	+$2.33K	﹤0.01%	748
2023 Q4	$2.09K	Buy	17 +8	+89%	+$998	﹤0.01%	773
2023 Q3	$1.17K	Buy	+9	New	+$1.2K	﹤0.01%	769

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Pinnacle Bancorp's JAZZ Position: Q2 2026 in Review

Pinnacle Bancorp sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 19 shares — an estimated $3.59K sold.

Pinnacle Bancorp first reported a position in JAZZ in Q3 2023 and held it in 11 quarters. The position peaked at $5.83K in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Pinnacle Bancorp reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Pinnacle Bancorp sold 19 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.59K.
Pinnacle Bancorp first reported a position in Jazz Pharmaceuticals in Q3 2023 and held it in 11 quarters.
Pinnacle Bancorp's Jazz Pharmaceuticals position peaked at $5.83K in Q1 2025.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.